Unexpected left atrial reinfusion through a patent foramen ovale during venovenous extracorporeal life support
Venovenous extracorporeal life support (VV-ECLS) is increasingly used as a supportive therapy for severe acute respiratory failure. We report a case of accidental left atrial reinfusion through a patent foramen ovale (PFO) during femorofemoral VV-ECLS.
A 36-year-old female was supported by femorofemoral VV-ECLS for primary graft dysfunction following bilateral lung transplantation. Cannulae position (drainage at L2 level and reinfusion at the end of the inferior vena cava) was checked by radioscopy and echography. The first days in intensive care were characterised by severe respiratory failure, and gas exchange was mainly provided by the extracorporeal bypass. The patient had no haemodynamic derangements with normal lactate levels and urine output, despite the pulmonary artery catheter showing unexpectedly low cardiac output (2-3 l/minute), with echocardiographic evidence of normal biventricular function. From day five respiratory function improved and we decided to remove ECLS, but the weaning test failed due to severe hypoxaemia. On day six we repeated the weaning test, but again, discontinuing the sweep gas suddenly led to unexpected severe hypoxaemia (SpO 2 from 100% to 70%) with unchanged PaCO 2 . Hypoxaemia was surprisingly related to a concomitant increase in shunt (from 24% to Correspondence 70%, Figure 1 ). An intracardiac shunt was initially ruled out by transthoracic echocardiography performed injecting microbubbles through the central venous line. Echography and radioscopy confirmed correct cannulae position. A computed tomography (CT) scan showed that the proportion of non-aerated to total lung tissue (the anatomical shunt compartment) was only 21% (consistent with the lowest values of functional shunt calculated), while the angio-CT arterial phase showed a small contrast-free area in the context of a totally enhanced left atrium. Overall, these findings suggested a preferential blood reinfusion into the left atrium through a PFO. The diagnosis was confirmed by evaluating the intrapulmonary shunt decreasing the blood flow (shunt decreased parallel to blood flow, Figure 1 ), and by contrast echocardiography obtained injecting microbubbles directly through the reinfusion cannula. ECLS was then successfully removed. Patient consent for data publication was obtained before discharge.
The incidence of PFO is about 25% in the general population, while right-to-left shunting across a PFO occurs only when right-sided pressures exceed the left-sided ones 1 . In this patient significant right-to-left shunt occurred even if central venous pressure (12 mmHg) was lower than pulmonary artery occlusion pressure (15 mmHg) and the reinfusion cannula was correctly positioned 2 . This could happen because, using a femorofemoral configuration, we applied a cranially directed reinfusion which mimics foetal circulation, when foramen ovale favours the well-oxygenated blood coming from the placenta to directly enter the left atrium, in order to optimise cerebral oxygenation. Foetal circulation, as well, can explain the false negative result of contrast echocardiography, when microbubbles were injected in the superior vena cava. Left atrial reinfusion may have some pathophysiological implications and, if unrecognised, could induce unpredictable clinical consequences.
First of all, our patient had normal left ventricular function: the 'right' cardiac output measured by the pulmonary artery catheter was quite low, but the effective 'left' ventricular cardiac output was somewhat higher, maintaining end-organ perfusion. Conversely, in the presence of left ventricular failure, a direct sustained left atrial influx could increase left atrial pressure, worsening hydrostatic pulmonary oedema.
On the other hand, this right-to-left intracardiac shunt reduces transpulmonary blood flow. Lung hypoperfusion may increase pulmonary inflammation 3 , although oxygen delivery to lung tissue may be preserved in ventilated lung regions 4 . Also, drug tissue penetration may be impaired in case of reduced pulmonary blood flow, and this could be clinically relevant for antibiotics 5 .
Moreover, the most suitable parameters to monitor respiratory function at the bedside during VV-ECLS are respiratory compliance and shunt across natural lungs. The latter cannot be reliable if well-oxygenated blood is directly injected in the arterial tree. Our weaning test in VV-ECLS is accomplished maintaining normal blood flow to reduce the risk of circuit thrombosis and turning off sweep gas flow. In this context, a 'gas-off' test apparently induces an increase in shunt proportional to extracorporeal blood flow, as happens during venoarterial bypass.
In conclusion, considering the high incidence of PFO and the possible implications of unrecognised left atrial reinfusion during VV-ECLS, we believe that such a situation should be taken in to account to better contextualise patient physiology to clinical decisions. 
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